Cover Image
市場調查報告書

生物性骨材的全球市場 - 2019年為止的預測:異體移植片,人工骨骼替代物,骨生長因子及脊椎刺激,幹細胞療法,關節內粘稠補充療法

Orthobiologics Market by Product (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Orthopedic Clinics) - Global Forecast to 2019

出版商 MicroMarketMonitor 商品編碼 328784
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
生物性骨材的全球市場 - 2019年為止的預測:異體移植片,人工骨骼替代物,骨生長因子及脊椎刺激,幹細胞療法,關節內粘稠補充療法 Orthobiologics Market by Product (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Orthopedic Clinics) - Global Forecast to 2019
出版日期: 2015年04月17日 內容資訊: 英文 99 Pages
簡介

由於可讓骨折迅速痊癒,縮短入院時間,以及回復快速,提升了大眾對生物性骨材的優點的認知。全球生物性骨材市場北美佔一半以上的51.2%。亞洲由於高齡化和糖尿病的增加,而以最快速度擴大中。

本報告提供全球生物性骨材市場相關資料詳細分析,提供您各產品,各終端用戶,各地區的趨勢,並彙整加入此市場的主要企業之詳細競爭趨勢與佔有率,簡介等資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 推動市場因素和阻礙因素
  • 主要的市場趨勢

第5章 各類型

  • 簡介
  • 全球生物性骨材市場
  • 全球人工骨骼替代物市場
  • 全球異體移植片市場
  • 全球幹細胞療法市場
  • 全球骨生長因子及脊椎刺激市場
  • 全球關節內粘稠補充療法市場

第6章 各終端用戶

  • 簡介
  • 醫院
  • 整形外科診所
  • 其他

第7章 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 競爭環境

  • 企業佔有率分析
  • 各產品企業概要
  • 合併·收購
  • 新產品上市
  • 擴大
  • 協定
  • 其他

第9章 各企業市場

  • Biomet, Inc.
  • Medtronic PLC
  • Integra Life Sciences Corporation
  • Stryker Corporation
  • Zimmer, Inc.
  • Depuy Synthes
  • Tornier, Inc.
  • Nuvasive, Inc.
  • Exactech, Inc.
  • Globus Medical Inc.
  • Wright Medical Technology, Inc.

第10章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OR 1000

The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019.

The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market.

The report has profiled leading players of this market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).

Reasons to Buy the Report:

This comprehensive research report has focused on various levels of analysis-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which constitute basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the orthobiologics market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to verify the current market conditions which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a customized combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies so as to exploit new clientele base and different pricing policies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market
  • Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players in order to enhance the bottom line of the companies in the orthobiologics market
  • Product/ Brand Perception Analysis: Comprehensive study of customer perception and behavior through our inbuilt social connect tools (digital marketing language) and checking the tenacity of blogs and social forums

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET
    • 2.1.1. TOP-DOWN APPROACH
    • 2.1.2. BOTTOM-UP APPROACH
    • 2.1.3. MACROINDICATOR-BASED APPROACH
  • 2.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. MARKET DRIVERS AND INHIBITORS
  • 4.3. KEY MARKET DYNAMICS

5. ORTHOBIOLOGICS MARKET, BY PRODUCT

  • 5.1. INTRODUCTION
  • 5.2. GLOBAL ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH PARENT MARKET
  • 5.3. GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY
  • 5.4. GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY
  • 5.5. GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY
  • 5.6. GLOBAL BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY GEOGRAPHY
  • 5.7. GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY

6. ORTHOBIOLOGICS MARKET, BY END-USER

  • 6.1. INTRODUCTION
  • 6.2. GLOBAL ORTHOBIOLOGICS MARKET HOSPITALS MARKET, BY GEOGRAPHY
  • 6.3. GLOBAL ORTHOPEDIC CLINICS MARKET, BY GEOGRAPHY
  • 6.4. GLOBAL ORTHOBIOLOGICS OTHER END-USERS MARKET, BY GEOGRAPHY

7. ORTHOBIOLOGICS MARKET, BY GEOGRAPHY

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA ORTHOBIOLOGICS MARKET
    • 7.2.1. NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT
    • 7.2.2. NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER
  • 7.3. EUROPE ORTHOBIOLOGICS MARKET
    • 7.3.1. EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT
    • 7.3.2. EUROPE ORTHOBIOLOGICS MARKET, BY END-USER
  • 7.4. ASIA ORTHOBIOLOGICS MARKET
    • 7.4.1. ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT
    • 7.4.2. ASIA ORTHOBIOLOGICS MARKET, BY END-USER
  • 7.5. REST OF THE WORLD (ROW) ORTHOBIOLOGICS MARKET
    • 7.5.1. ROW ORTHOBIOLOGICS MARKET, BY PRODUCT
    • 7.5.2. ROW ORTHOBIOLOGICS MARKET, BY END-USER

8. ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE

  • 8.1. ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS
  • 8.2. COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT
  • 8.3. MERGERS & ACQUISITIONS
  • 8.4. NEW PRODUCT LAUNCHES
  • 8.5. EXPANSIONS
  • 8.6. AGREEMENTS
  • 8.7. OTHER DEVELOPMENTS

9. ORTHOBIOLOGICS MARKET, BY COMPANY (Overview, Financials, Products & Services, Strategy, and Developments)*

  • 9.1. BIOMET, INC.
  • 9.2. MEDTRONIC PLC
  • 9.3. INTEGRA LIFE SCIENCES CORPORATION
  • 9.4. STRYKER CORPORATION
  • 9.5. ZIMMER, INC.
  • 9.6. DEPUY SYNTHES (JOHNSON & JOHNSON FAMILY OF COMPANIES)
  • 9.7. TORNIER, INC.
  • 9.8. NUVASIVE, INC.
  • 9.9. EXACTECH, INC.
  • 9.10. GLOBUS MEDICAL INC.
  • 9.11. WRIGHT MEDICAL TECHNOLOGY, INC.

*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10. APPENDIX

  • 10.1. CUSTOMIZATION OPTIONS
    • 10.1.1. REGULATORY FRAMEWORK
    • 10.1.2. EPIDEMIOLOGY DATA
    • 10.1.3. SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
    • 10.1.4. IMPACT ANALYSIS
  • 10.2. RELATED REPORTS
  • 10.3. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
    • 10.3.1. RT SNAPSHOTS

LIST OF TABLES

  • TABLE 1: GLOBAL ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN)
  • TABLE 2: GLOBAL ORTHOBIOLOGICS MARKET: MACROINDICATOR, BY COUNTRY, 2014
  • TABLE 3: GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
  • TABLE 4: GLOBAL ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS
  • TABLE 5: GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 6: GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 7: GLOBAL ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
  • TABLE 8: GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 9: GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 10: GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 11: GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 12: GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 13: GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013-2019 (USD MN)
  • TABLE 14: GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 15: GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 16: GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-USERS, BY GEOGRAPHY, 2013 - 2019 (USD MN)
  • TABLE 17: GLOBAL ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 18: NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 19: NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • TABLE 20: EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 21: EUROPE ORTHOBIOLOGICS MARKET , BY END-USER, 2013-2019 (USD MN)
  • TABLE 22: ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 23: ASIA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • TABLE 24: ROW ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • TABLE 25: ROW ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • TABLE 26: ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
  • TABLE 27: GLOBAL ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS
  • TABLE 28: GLOBAL ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES
  • TABLE 29: GLOBAL ORTHOBIOLOGICS MARKET: EXPANSIONS
  • TABLE 30: GLOBAL ORTHOBIOLOGICS MARKET: AGREEMENTS
  • TABLE 31: GLOBAL ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS
  • TABLE 32: BIOMET, INC.: KEY FINANCIALS, 2011-2013 (USD MN)
  • TABLE 33: MEDTRONIC, PLC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 34: INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (USD MN)
  • TABLE 35: STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 36: ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 37: DEPUY SYNTHES: KEY FINANCIALS, 2011-2013 (USD MN)
  • TABLE 38: TORNIER, INC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 39: NUVASIVE, INC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 40: EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 41: GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (USD MN)
  • TABLE 42: WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (USD MN)

LIST OF FIGURES

  • FIGURE 1: GLOBAL ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE
  • FIGURE 2: ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: MACROINDICATOR-BASED APPROACH
  • FIGURE 6: GLOBAL ORTHOBIOLOGICS MARKET SNAPSHOT
  • FIGURE 7: GLOBAL ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET
  • FIGURE 8: GLOBAL ORTHOBIOLOGICS PRODUCTS, BY GEOGRAPHY, 2014 (USD MN)
  • FIGURE 9: GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • FIGURE 10: GLOBAL ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
  • FIGURE 11: GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 12: GLOBAL BONE ALLOGRAFTS MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN)
  • FIGURE 13: GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 14: GLOBAL BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 15: GLOBAL VISCOSUPPLEMENTATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 16: GLOBAL ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • FIGURE 17: GLOBAL ORTHOBIOLOGICS MARKET IN HOSPITALS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 18: GLOBAL ORTHOPEDIC MARKET IN CLINICS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 19: GLOBAL ORTHOBIOLOGICS MARKET IN OTHER END-USERS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 20: GLOBAL ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY GEOGRAPHY, 2014-2019 (USD MN)
  • FIGURE 21: NORTH AMERICA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 22: NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • FIGURE 23: NORTH AMERICA: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
  • FIGURE 24: NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • FIGURE 25: NORTH AMERICA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT (%)
  • FIGURE 26: EUROPE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 27: EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • FIGURE 28: EUROPE ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
  • FIGURE 29: EUROPE ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • FIGURE 30: EUROPE: ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT
  • FIGURE 31: ASIA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 32: ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • FIGURE 33: ASIA ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
  • FIGURE 34: ASIA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • FIGURE 35: ASIA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT
  • FIGURE 36: ROW ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 37: ROW ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN)
  • FIGURE 38: ROW ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT
  • FIGURE 39: ROW ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN)
  • FIGURE 40: ROW ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT
  • FIGURE 41: ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 42: ORTHOBIOLOGICS: COMPANY PRODUCT COVERAGE, 2013
  • FIGURE 43: BIOMET, INC.: REVENUE MIX, 2013 (%)
  • FIGURE 44: CONTRIBUTION OF SPINE, BONE HEALING, AND MICROFIXATION SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
  • FIGURE 45: MEDTRONIC, PLC. REVENUE MIX, 2013 (%)
  • FIGURE 46: CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 47: INTEGRA LIFE SCIENCES CORPORATION REVENUE MIX, 2013 (%)
  • FIGURE 48: CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2010-2013 (USD MN)
  • FIGURE 49: STRYKER CORPORATION REVENUE MIX, 2013 (%)
  • FIGURE 50: CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 51: ZIMMER, INC.: REVENUE MIX, 2013 (%)
  • FIGURE 52: CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 53: DEPUY SYNTHES REVENUE MIX, 2013 (%)
  • FIGURE 54: TORNIER, INC.: REVENUE MIX 2013 (%)
  • FIGURE 55: CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 56: NUVASIVE, INC.: REVENUE MIX 2013 (%)
  • FIGURE 57: CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN)
  • FIGURE 58: EXACTECH, INC.: REVENUE MIX 2013 (%)
  • FIGURE 59: CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 60: GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%)
  • FIGURE 61: CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN)
  • FIGURE 62: WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%)
  • FIGURE 63: CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES, 2011 - 2013 (USD MN)
Back to Top